Left Menu
Development News Edition

Mexico consulting with China, Oxford and AstraZeneca on coronavirus vaccine trials

Mexico is in talks with the Chinese government and private Chinese laboratories, as well as the University of Oxford and company AstraZeneca about running trials for experimental COVID-19 vaccines, a senior Mexican official said on Monday.

Reuters | Updated: 30-06-2020 05:02 IST | Created: 30-06-2020 05:02 IST
Mexico consulting with China, Oxford and AstraZeneca on coronavirus vaccine trials

Mexico is in talks with the Chinese government and private Chinese laboratories, as well as the University of Oxford and company AstraZeneca about running trials for experimental COVID-19 vaccines, a senior Mexican official said on Monday. More than 100 vaccines against the novel coronavirus, which has killed hundreds of thousands of people and ravaged the global economy, are now being developed and tested by various teams around the world.

Martha Delgado, a Mexican deputy foreign minister, told Reuters the government was seeking to collaborate with different countries and laboratories that are working on experimental vaccines. Delgado said no decision has been made so far, and she did not elaborate on what the collaborations could entail. Four Mexican teams have joined the vaccine race.

"We've had conversations with the people who are developing the vaccine at the University of Oxford and also directly with AstraZeneca," Delgado said. "We've had conversations with laboratories and the Chinese government." The University of Oxford, AstraZeneca and the Chinese embassy in Mexico City were not immediately available for comment.

Esther Orozco, who leads the research efforts in Mexico, said the race among Mexican researchers will continue even if other countries beat them to the first vaccine. "It won't be easy and one vaccine will not cover the necessities of everyone," she said. "Mexico can't wait for another country, no matter how advanced."

There is broad agreement among scientists that a vaccine is essential to ending the pandemic. Still, running large-scale clinical trials of potential vaccines against a completely new disease at speed is complex. A key task for scientists is to chase fluctuating outbreaks and seek volunteers in sections of populations or in countries where the disease is still rife.

Delgado said Mexico was also exploring what role it could carve out on the purchase, manufacturing and distribution of vaccines. "Right now we are simply mapping capabilities to know how much Mexico could do," she said. Transmission rates of the coronavirus are on the rise in Mexico and most other Latin American countries.


TRENDING

OPINION / BLOG / INTERVIEW

5G will be the key driving force for COVID-19 recovery: Here's how?

... ...

Canada’s COVID-19 pitfalls highlight need for integrated health information system

In the globalized world of today where outbreaks can spread far and wide within a matter of days, a global-level integrated health information system is ideal but Canadas provincial barriers show that the country lags much behind in deployi...

Pandemic must be impetus, not obstacle, for clean water access

To make matters worse, there are suspicions that the inadequacy of wastewater treatment methods in California, the rest of the USA, and indeed around the world may help to propagate the disease even more widely. ...

3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...

Videos

Latest News

Forced break has made it more challenging for wrestlers who are yet to qualify for Olympics: Bajrang

Indias ace wrestler Bajrang Punia says competition time lost due to the coronavirus pandemic has made it more challenging for those who are yet to qualify for the postponed Tokyo Olympics. Bajrang said grapplers like him, who have already s...

India exported 23 lakh PPE to 5 countries in July: Health ministry

India exported 23 lakh personal protection equipment to five countries including the US, the UK and the UAE in July, after the government relaxed export norms and this has substantially helped the country to position itself in the global ma...

On this day in 1990, Tendulkar scored his maiden international ton

On this day in 1990, the 17-year-old batsman Sachin Tendulkar scored his first international hundred in a Test match against England at Old Trafford. At the age of 17 years and 112 days, he became the third-youngest batsman to score a Test ...

Bank lending to NBFCs jumps 190 bps to 8.8 pc since Sept 2018

Amid continuing calls for more bank loans to non-banking lenders, the latest data showed that banks have already been lending more to them increasing their overall exposure to NBFCs by 190 basis points to 8.8 per cent between September 2018...

Give Feedback